(Q39976555)

16 September 2017

title

Valproic acid inhibits the growth of cervical cancer both in vitro and in vivo (English)

1 reference

16 September 2017

main subject

cervix uterine cancer

1 reference

Siraj Sami

1

1 reference

16 September 2017

Naseruddin Höti

2

1 reference

16 September 2017

Han-Mei Xu

3

1 reference

16 September 2017

Zilong Shen

4

1 reference

16 September 2017

Xiaofeng Huang

5

1 reference

16 September 2017

language of work or name

1 reference

31 May 2008

1 reference

16 September 2017

published in

Journal of Biochemistry

1 reference

16 September 2017

volume

144

1 reference

16 September 2017

issue

3

1 reference

16 September 2017

page(s)

357-362

1 reference

Targeting the heat shock factor 1 by RNA interference: a potent tool to enhance hyperthermochemotherapy efficacy in cervical cancer.

16 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVN074

Molecular biology of cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVN074

Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVN074

Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVN074

Evolving anticancer drug valproic acid: insights into the mechanism and clinical studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVN074

The mood stabilizer valproic acid activates mitogen-activated protein kinases and promotes neurite growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVN074

Valproic acid induces extracellular signal-regulated kinase 1/2 activation and inhibits apoptosis in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVN074

Anti-tumor mechanisms of valproate: a novel role for an old drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVN074

Valproate and valproate-analogues: potent tools to fight against cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVN074

Metastasis: cell-autonomous mechanisms versus contributions by the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVN074

Valproic acid modulates NCAM polysialylation and polysialyltransferase mRNA expression in human tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVN074

Role of angiogenesis in human tumor dormancy: animal models of the angiogenic switch

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVN074

Angiogenesis inhibitors: perspectives for medical, surgical and radiation oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVN074

Valproic acid inhibits angiogenesis in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVN074

Valproic Acid prolongs survival time of severe combined immunodeficient mice bearing intracerebellar orthotopic medulloblastoma xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVN074

Angiogenesis in gynecological oncology-mechanism of tumor progression and therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVN074

Valproic acid, a histone deacetylase inhibitor, is an antagonist for oncolytic adenoviral gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVN074

The global health burden of infection-associated cancers in the year 2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVN074

Anticancer activities of histone deacetylase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVN074

Histone acetylation and histone deacetylase activity of magnesium valproate in tumor and peripheral blood of patients with cervical cancer. A phase I study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVN074

Triphenyl tin benzimidazolethiol, a novel antitumor agent, induces mitochondrial-mediated apoptosis in human cervical cancer cells via suppression of HPV-18 encoded E6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVN074

Histone deacetylase inhibitor trichostatin A induces cell-cycle arrest/apoptosis and hepatocyte differentiation in human hepatoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVN074

Functional interplay between modulation of histone deacetylase activity and its regulatory role in G2–M transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVN074

Histone deacetylase inhibitor, Trichostatin A, activates p21WAF1/CIP1 expression through downregulation of c-myc and release of the repression of c-myc from the promoter in human cervical cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVN074

Role of hTERT in apoptosis of cervical cancer induced by histone deacetylase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVN074

Inhibitors of histone deacetylase arrest cell cycle and induce apoptosis in cervical carcinoma cells circumventing human papillomavirus oncogene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVN074

Chronic administration of valproic acid inhibits prostate cancer cell growth in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVN074

Effects of chronic administration of olanzapine, amitriptyline, haloperidol or sodium valproate in naive and anhedonic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVN074

Sodium valproate exerts neuroprotective effects in vivo through CREB-binding protein-dependent mechanisms but does not improve survival in an amyotrophic lateral sclerosis mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVN074

Carcinogenicity of human papillomaviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJB%2FMVN074

21 January 2018

Identifiers

DOI

10.1093/JB/MVN074

1 reference

16 September 2017

1 reference